MedPath

Trial on Early Induction Versus Expectant Management of Nulliparous Women With a Prolonged Latent Phase

Not Applicable
Completed
Conditions
Nulliparous Women With Prolonged Latent Phase
Registration Number
NCT01863797
Lead Sponsor
Karolinska Institutet
Brief Summary

The purpose of the study was to compare early induction versus expectant management regarding outcome and experience of delivery in nulliparous women with a prolonged latent phase.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
138
Inclusion Criteria
  • generally healthy nulliparous women and normal pregnancies (in vitro-fertilisation included)
  • with a singleton fetus in cephalic presentation,
  • gestational age between 37+0 and 41+6,
  • continuous contractions exceeding 18 hours impeding rest (women's report),
  • a cervical dilation of less than four centimetres and intact membranes. Gestational age was confirmed by ultrasound in the first trimester.

Women had to be able to read, understand and speak Swedish.

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The primary outcome was mode of delivery (caesarean sections and vaginal deliveries (spontaneous and instrumental))Participants will be followed for the duration of hospital stay, an expected average of 3 days
Secondary Outcome Measures
NameTimeMethod
Maternal outcome measure included experience of deliveryExperience of delivery was assessed two days after delivery

Wijma Delivery Experience Questionnaire - validated instrument. The 33 question questionnaire was filled in by the participance two days after delivery at postnatal care unit or at home.

Trial Locations

Locations (1)

Förlossningen, Danderyd Hospital

🇸🇪

Stockholm, Sweden

Förlossningen, Danderyd Hospital
🇸🇪Stockholm, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.